SYRE
Spyre TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
SYRE vs peer average
24/100
SYRE vs. peer average (F vs. C)
Grade spread
A 1 · B 1 · C 2 · D 5 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
SRPT is the first available peer comparator.
Rare-disease biotech with commercialization experience; useful comparator for regulatory and launch execution risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SYRE
Spyre Therapeutics
SRPT
Sarepta Therapeutics
Grade
F
B
Momentum
51
85
Value
41
51
Sentiment
19
65
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs SRPT
SYRE / SRPT
Grade Position
Below peers
SYRE vs. peer average (F vs. C)
24/100
Momentum
51
SRPTValue
41
SRPTSentiment
19
SRPTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SYRE
SRPT is the first peer returned for this comparison set.